Article info
PDFBrief communication
Iatrogenic antibody deficiency from B-cell targeted therapies in autoimmune rheumatic diseases
- Correspondence to Dr Mohammed Yousuf Karim; mkarim{at}sidra.org
Citation
Iatrogenic antibody deficiency from B-cell targeted therapies in autoimmune rheumatic diseases
Publication history
- Received April 24, 2019
- Revision received July 14, 2019
- Accepted July 17, 2019
- First published July 30, 2019.
Online issue publication
January 19, 2024
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.